Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency-Reference-Cited by-同舟云学术

Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency

Published:2016-11 Issue:11 Volume:101 Page:3879-3883
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Muñoz-Calvo María T.,Barrios Vicente,Pozo Jesús,Chowen Julie A.,Martos-Moreno Gabriel Á.,Hawkins Federico,Dauber Andrew,Domené Horacio M.,Yakar Shoshana,Rosenfeld Ron G.,Pérez-Jurado Luis A.,Oxvig Claus,Frystyk Jan,Argente Jesús

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic analysis of the PAPP-A2 gene and evaluation of free IGF-1, IGFBP-5, and ALS concentrations in a group of 22 patients with idiopathic short stature;Endokrynologia Polska;2024-07-02

2. Sex-based differences in growth-related IGF1 signaling in response to PAPP-A2 deficiency: comparative effects of rhGH, rhIGF1 and rhPAPP-A2 treatments;Biology of Sex Differences;2024-04-08

3. Sex-based differences in IGF1 signaling pathways in response to PAPP-A2 deficiency;2023-01-30

4. Five-Year Therapy with Recombinant Human Insulin-Like Growth Factor-1 in a Patient with PAPP-A2 Deficiency;Hormone Research in Paediatrics;2023

5. Pappalysins and Stanniocalcins and Their Relationship With the Peripheral IGF Axis in Newborns and During Development;The Journal of Clinical Endocrinology & Metabolism;2022-07-29